Enhanced Harm Reduction Working Group
The Enhanced Harm Reduction Working Group is a consortium of scientific experts, academics, policy makers, treatment providers and advocacy groups, working collaboratively to reduce the harms of intravenous drug use.
To develop the evidence base for reducing drug-related harm by piloting a Supervised Injection Facility (SIF) in the UK
We believe that there is good real-world evidence for the positive effects of Supervised Injection Facilities (SIFs) across the world.
SIFs are known by many names including Overdose Prevention Centres, and Drug Consumption Rooms. There are subtle nuances between each, however, their
function is to provide safe spaces for people to consume controlled drugs under the supervision of people who can save lives if overdoses occur.
Our aim is to develop the evidence base for reducing drug-related harms by piloting a SIF in the UK. This collaborative initiative will evaluate whether establishing a SIF would prove to be cost-effective, reduce crime, improve public health, reduce drug litter, and increase engagement in treatment services.
The EHRWG encourages the use of a participatory development approach in the design and development of a SIF. Consulting people who will be the end users of the SIF in the design, development and implementation is key to ensuring the model is fit for purpose, community-friendly, and holds the confidence of the local drug-using community. People who use drugs are sadly familiar with experiencing discrimination in health and social care settings. As such, those developing new services need to actively demonstrate their commitment to non-judgemental, rights-based approach and participatory development is a good starting point. When a community owns and supports the SIF, this ensures effective service user recruitment, quality management and advocacy.
Professor of Criminal Justice
Professor of Neuro-psychopharmacology
Chair in Criminology
Professor of Public Health
Professor of Social Policy and Criminal Justice
Editor of the British Journal of General Practice
Reader in Psychology
Consultant Addiction Psychiatrist
Associate Professor in the Sociology of Health
Drug Science Scientific Committee
Research Associate, Kings College London
Reader in Public Health,
Glasgow Caledonian University
Head of Legal Services, Release
Associate Consultant, IDPC
Deputy Director, Harm Reduction International
Detective Chief Inspector, Thames Valley Police
Head of Partnerships, Transform
Strategy Coordinator, Scottish Drugs Forum
Treatment Provider Representatives
Deputy Director of Clinical Practice, Change Grow Live
Associate Director, With You
Campaigns and Communications Lead, Barod
Project Lead – Cranstoun
Regional Director, Humankind
Clinical Partner, Foundations
The Enhanced Harm Reduction Working Group is supported by treatment providers to ensure that the stakeholders who would be delivering these services are consulted throughout.